|
|
Article: KOREA'S LGCI DEVELOPS NEW HUMAN GROWTH HORMONE INJECTION.
- Article from:
- AsiaPulse News
- Article date:
- July 10, 2001
CopyrightCOPYRIGHT 2001 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEOUL, July 10 Asia Pulse - LG Chem Investment (KSE:03550) has developed its first intravenous human growth hormone, which produces significant gains with just one shot per week.
The new drug is a slow-release human growth hormone, LBO3002, which dissolves through the blood stream, and LGCI is pursuing a second-round of clinical tests to secure approval from the Food and Drug Administration (FDA) after completing the first-round of clinical tests.
The company attributes LBO3002's effectiveness to its mixture of existing human growth hormone elements and sodium hyaluronatebe. LG says the body can easily absorb the particles equally throughout its system ...